Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2R,5S,8S,11S,14S,17S)-1-((S)-2-((5R,8S,11S,14S,17S,20S)-1-amino-14-(2-carboxyethyl)-17-(carboxymethyl)-8-isobutyl-5-(mercaptomethyl)-11-methyl-1,4,7,10,13,16,19-heptaoxo-3,6,9,12,15,18-hexaazahenicosan-20-ylcarbamoyl)pyrrolidin-1-yl)-5-(2-amino-2-oxoethyl)-17-((S)-2-((R)-2-((S)-2-aminopropanamido)-3-mercaptopropanamido)-3-hydroxypropanamido)-11-benzyl-8,14-bis(3-guanidinopropyl)-2-(mercaptomethyl)-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid
ID: ALA1240701
Chembl Id: CHEMBL1240701
Max Phase: Preclinical
Molecular Formula: C72H115N25O25S3
Molecular Weight: 1827.06
Molecule Type: Protein
Associated Items: